8-K: Current report
8-K: Current report
424B3: Prospectus
424B3: Prospectus
10-Q: Q2 2024 Earnings Report
10-K/A: Annual report (Amendment)
10-Q/A: Quarterly report (Amendment)
10-Q/A: Quarterly report (Amendment)
NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
8-K: Current report
8-K: Current report
D: Filing D
8-K: Current report
10-Q: Q1 2024 Earnings Report
Coeptis Therapeutics | 10-K: FY2023 Annual Report
Coeptis Therapeutics | 424B3: Prospectus
Coeptis Therapeutics | 424B3: Prospectus
Coeptis Therapeutics | 10-Q/A: Q1 2022 Earnings Report
Coeptis Therapeutics | 10-Q/A: Q1 2022 Earnings Report
Coeptis Therapeutics | 10-Q/A: Q1 2022 Earnings Report
No Data
No Data